Lowy Discusses Reducing Cuts to Modular R01 Grants

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Following Harold Varmus’s remarks to the Board of Scientific Advisors, Douglas Lowy, soon-to-be acting director of the NCI, focused on reducing the amount of the planned cuts for modular R01 grants.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

YOU MAY BE INTERESTED IN

The College of American Pathologists in collaboration with the International Association for the Study of Lung Cancer, Pulmonary Pathology Society, Association for Molecular Pathology, and the LUNGevity Foundation have developed evidence-based recommendations for the testing of immunotherapy biomarkers, including programmed cell death ligand-1 and tumor mutation burden in patients with non-small cell lung carcinoma.

Login